Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
Journal of the American Academy of Dermatology|December 26, 2025
Updates in Adjuvant and Neoadjuvant Therapies for Resectable Cutaneous MelanomaMatthew J Hadfield, Sonal Muzumdar, Ryan J Sullivan, et al.Journal of the American Pharmacists Association : Japha|March 22, 2020
Pharmacist intervention in colorectal cancer screening initiativeLisa M Holle, Joel Levine, Thomas Buckley, et al.International Journal of Molecular Sciences|February 25, 2023
Advances in Liquid Biopsy Technology and Implications for Pancreatic CancerAlexander G Raufi, Michael S May, Matthew J Hadfield, et al.Current Oncology Reports|June 3, 2025
Merkel Cell Carcinoma: Current Treatment Landscape and Emerging Therapeutic TargetsKelly Pan, A Maria Vromans, Liang Cheng, et al.Oncogene|January 28, 2024
Overcoming resistance to programmed cell death protein 1 (PD-1) blockade with allogeneic invariant natural killer T-cells (iNKT)Matthew J Hadfield, Howard Safran, Marco A Purbhoo, et al.Cancer|November 15, 2019
Neurologic complications of melanomaJustine V Cohen, Nancy Wang, Vyshak A Venur, et al.NPJ Precision Oncology|November 14, 2025
The evolving landscape of antibody-drug conjugates (ADCs) for treatment of prostate cancerClaire Lin, Matthew J Hadfield, Ariana Santopietro, et al.Clinical Therapeutics|June 2, 2026
Clinical Characteristics and Outcomes of Immune Checkpoint Inhibitor Associated Renal Toxicities: A Retrospective Pan-Cancer Cohort StudyCharmi Trivedi, Julia Contini, MacKenzie Adams, et al.Cancer Treatment Reviews|December 2, 2025
Cellular senescence: A novel mechanism of therapeutic resistance in prostate cancerClaire Lin, Matthew J Hadfield, Amol Rathore, et al.Cancer Research Communications|November 13, 2025
BrUOG360: A Phase Ib/II Study of Copanlisib in Combination with Rucaparib in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC)Andre L De Souza, Matthew J Hadfield, Shaolei Lu, et al.Pageof 4